Entry |
|
Name |
Sergliflozin etabonate (USAN) |
Formula |
C23H28O9
|
Exact mass |
448.1733
|
Mol weight |
448.463
|
Structure |
|
Class |
|
Efficacy |
Antidiabetic, SGLT-2 inhibitor |
Comment |
Treatment of type 2 diabetes
|
Target |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01794 SGLT2 inhibitor
D06641 Sergliflozin etabonate
Target-based classification of drugs [BR:br08310]
Transporters
Solute carrier family
SLC5
SLC5A2 (SGLT2)
D06641 Sergliflozin etabonate (USAN)
|
Other DBs |
|
KCF data |
ATOM 32
1 C1y C 12.1800 -25.3400
2 C1y C 12.1800 -26.7400
3 C1y C 13.3924 -27.4400
4 C1y C 14.6049 -26.7400
5 O2x O 14.6049 -25.3400
6 C1y C 13.3924 -24.6400
7 O2a O 15.8360 -27.4510
8 C8y C 15.8360 -28.8510
9 C8x C 14.6165 -29.5552
10 C8x C 14.6166 -30.9552
11 C8x C 15.8291 -31.6551
12 C8x C 17.0486 -30.9509
13 C8y C 17.0485 -29.5509
14 C1b C 18.2892 -28.8343
15 C8y C 19.4897 -29.5273
16 C8x C 19.4900 -30.9397
17 C8x C 20.7027 -31.6394
18 C8y C 21.9149 -30.9390
19 C8x C 21.9145 -29.5267
20 C8x C 20.7019 -28.8270
21 O2a O 23.1243 -31.6368
22 C1a C 24.3169 -30.9477
23 O1a O 13.3924 -28.8398
24 O1a O 10.9676 -27.4400
25 O1a O 10.9676 -24.6400
26 C1b C 13.3924 -23.2402
27 O7a O 12.1632 -22.5303
28 C7a C 12.1632 -21.1303
29 O6a O 13.3839 -20.4254
30 O7a O 10.9675 -20.4401
31 C1b C 9.7721 -21.1305
32 C1a C 8.5847 -20.4450
BOND 34
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1 #Up
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 13 14 1
16 14 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 18 19 1
21 19 20 2
22 15 20 1
23 18 21 1
24 21 22 1
25 3 23 1 #Down
26 2 24 1 #Up
27 1 25 1 #Down
28 6 26 1 #Up
29 26 27 1
30 27 28 1
31 28 29 2
32 28 30 1
33 30 31 1
34 31 32 1
|